Comparison of PPIand P-CAB in the gastric ulcer healing after endoscopic submucosal dissection

Comparison of PPIand P-CAB in the gastric ulcer healing after endoscopic submucosal dissection - Comparison of PPIand P-CAB in the gastric ulcer healing after endoscopic submucosal dissection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016835

Enrollment

Registered

2015-03-18

Start date

2015-03-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer, gastric adenoma

Interventions

vonoprazan fumarate20mg+rebamipide300mg esomeprazole20mg+rebamipide300mg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo ESD for gastric cancer or gastric adenoma. Patients who give a written informed consent.

Exclusion criteria

Exclusion criteria: Pregnancy or lactation. Past history of allergy for the drugs used in this therapy. Patients on some form of antithrombotic therapy or NSAIDs, adrenocorticosteroid. Severe liver dysfunction, Severe renal dysfunction, Severe heart dysfunction. Patients who are disqualified for the study by physicians.

Design outcomes

Primary

Measure	Time frame
Reduction of the size of the gastric ulcer after ESD	—

Secondary

Measure	Time frame
Rate of post-operative bleeding	—

Countries

Japan

Contacts

Public ContactYasuaki Ishii

Yokohama City University Hospital Gastroenterology

t146009d@yokohama-cu.ac.jp045-261-5656

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026